1. Merck CEO Frazier says COVID vaccine hype a 'grave disservice' to the public — Why Inovio is the front runner in COVID vaccine development — Biogen and Eisai trial drug in asymptomatic Alzheimer's — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Binosto

Discussion in 'Mission Pharmacal' started by Anonymous, Nov 19, 2012 at 4:49 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Eerie how similar this is to Cambia Launch. Anyone else getting nervous?
     

  2. Anonymous

    Anonymous Guest

    Wasn't here for that launch, how did it go? Yes getting nervous.
     
  3. Anonymous

    Anonymous Guest

    Makes me want to hang a hat on a bums pecker
     
  4. Anonymous

    Anonymous Guest

    Stay close to the customers that know you. Don't fall in the trap of reach and frequency and ask for generic switches. Don't get stuck on apricot.
     
  5. Anonymous

    Anonymous Guest

    I hate this product. Once again failed to do adequate pre launch research. And these weekly Binosto calls are getting real annoying.
     
  6. Anonymous

    Anonymous Guest

    I agree. What were they thinking? And with the generic intrusion into our other product markets, I must say that I am getting concerned about keeping my head above the water.
     
  7. Anonymous

    Anonymous Guest

    Cambia was a smoldering disaster and a massive bust, one of Wild Card's smoldering turd piles. Is he still banging the inventiv rep in Jersey? Although I'm sure the barely lingual bear was right behind it too. You know the 2nd generation usually runs their dad's company into the ground repeatedly at high speed. What a horrible company to work for.
     
  8. Anonymous

    Anonymous Guest

    This drug is a joke- doctors know it and call it a "me too" drug. C'mon- no studies and crappy manged care. Mission got greedy and jumped to fast on this. Typical "small Pharma" mistake.
     
  9. Anonymous

    Anonymous Guest

    I believe Mr. Herring chooses the products we sell...
     
  10. Anonymous

    Anonymous Guest

    That's just what a doctor want some annoying little sales rep bugging them every week with some crappy product. You people are killing the industry
     
  11. Anonymous

    Anonymous Guest

    How are sales going with this great new novel product ?